Table 1.
Correlation between PODXL expression and clinicopathological parameters in patients with pancreatic ductal adenocarcinoma
| PODXL expression | P‐value | ||
|---|---|---|---|
| Low (%) | High (%) | ||
| Stage† | |||
| 0 | 2.7 (n = 2) | 0.0 (n = 0) | 0.710 |
| IA | 4.2 (n = 3) | 3.3 (n = 1) | |
| IB | 9.7 (n = 7) | 3.3 (n = 1) | |
| IIA | 33.3 (n = 24) | 26.7 (n = 8) | |
| IIB | 43.2 (n = 31) | 63.4 (n = 19) | |
| III | 2.7 (n = 2) | 0.0 (n = 0) | |
| IV | 4.2 (n = 3) | 3.3 (n = 1) | |
| Primary tumor† | |||
| Tis | 2.7 (n = 2) | 0.0 (n = 0) | 0.973 |
| T1 | 5.4 (n = 4) | 6.6 (n = 2) | |
| T2 | 14.1 (n = 10) | 16.7 (n = 5) | |
| T3 | 75.1 (n = 54) | 76.7 (n = 23) | |
| T4 | 2.7 (n = 2) | 0.0 (n = 0) | |
| Regional lymph nodes† | |||
| N0 | 50.0 (n = 36) | 36.7 (n = 11) | 0.277 |
| N1 | 50.0 (n = 36) | 63.3 (n = 19) | |
| Distant metastasis† | |||
| M0 | 95.8 (n = 69) | 96.7 (n = 29) | 1.000 |
| M1 | 4.2 (n = 3) | 3.3 (n = 1) | |
| Histology‡ | |||
| PanIN | 2.7 (n = 2) | 0.0 (n = 0) | 0.048 |
| Well | 33.3 (n = 24) | 20.0 (n = 6) | |
| Moderate | 59.8 (n = 43) | 60.0 (n = 18) | |
| Poor | 4.2 (n = 3) | 20.0 (n = 6) | |
| Venous invasion‡ | |||
| v0 + v1 | 90.3 (n = 65) | 76.7 (n = 23) | 0.110 |
| v2 + v3 | 9.7 (n = 7) | 23.3 (n = 7) | |
| Lymphatic invasion‡ | |||
| ly0 + ly1 | 77.8 (n = 56) | 70.0 (n = 21) | 0.452 |
| ly2 + ly3 | 22.2 (n = 16) | 30.0 (n = 9) | |
†Classified according to the International Union against Cancer. ‡Classified according to the classification of pancreatic cancer by the Japan Pancreas Society. PanIN, pancreatic intraepithelial neoplasia; Tis, carcinoma in situ.